John Robert Vane
Vane, John Robert, 1927-2004
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Vane, John R.
Vane, John R., 1927-
Vane, John R., 1927-2004
ויין, ג'ון ר.
Vane, John Robert, 1927-
Vane, John R. (John Robert), 1927-
VIAF ID: 110349841 (Personal)
Permalink: http://viaf.org/viaf/110349841
Preferred Forms
-
100 0 _
‡a
John Robert Vane
-
200 _ |
‡a
Vane
‡b
John Robert
‡f
1927-2004
-
100 1 _ ‡a Vane, John R
-
100 1 _ ‡a Vane, John R.
-
100 1 _ ‡a Vane, John R.
-
100 1 _ ‡a Vane, John R.
-
100 1 _
‡a
Vane, John R.
-
100 1 _
‡a
Vane, John R.
-
100 1 _ ‡a Vane, John R. ‡d (1927- ).
-
100 1 _
‡a
Vane, John R.
‡d
1927-2004
-
100 1 _ ‡a Vane, John R. ‡q (John Robert), ‡d 1927-
-
100 1 _ ‡a Vane, John R., ‡d 1927-
-
100 1 _ ‡a Vane, John R., ‡d 1927-2004
-
100 1 _ ‡a Vane, John Robert ‡d (1927-2004)
-
100 1 _
‡a
Vane, John Robert
‡d
1927-2004
-
100 1 _ ‡a Vane, John Robert, ‡d 1927-
-
100 1 _
‡a
Vane, John Robert,
‡d
1927-2004
-
100 1 _ ‡a Vane, John Robert, ‡d 1927-2004
-
100 1 _ ‡a ויין, ג'ון ר.
4xx's: Alternate Name Forms (53)
5xx's: Related Names (2)
- 551 _ _
‡a
Farnborough
‡g
London
- 551 _ _
‡a
Tardebigge
Works
| Title | Sources |
|---|---|
| Adv. clin. pharmacol. (New York N.Y.) |
|
| Aspirin and other salicylates |
|
| Asthma : basic mechanisms and therapeutic perspectives |
|
| Ciba Foundation Symposium jointly with Committee for Symposia on Drug Action, on Adrenergic Mechanisms. [Papers and discussions] |
|
| Eicosanoids, aspirin and asthma |
|
| The endothelial cell in health and disease |
|
| Endothelin II : proceedings of the second international conference on endothelin, held at the University of Tsukuba, Japan, December 9-12, 1990 |
|
| Endothelium as a regulator of vascular tone and growth |
|
| Improved non-steroid anti-inflammatory drugs COX-2 enzyme inhibitors : proceedings of a conference held on October 10-11, 1995, at Regent's College, London |
|
| Inflammation |
|
| Interaction of the platelets and the vessel walls |
|
| Jubileusz 30-lecia Centrum Medycyny Doświadczalnej i Klinicznej PAN, Warszawa, 13-16 października 1997 r. |
|
| Metabolic functions of the lung |
|
| The mode of action of aspirin-like drugs |
|
| Najważniejsze: obudzić się! |
|
| New targets in inflammation : inhibitors of COX-2 or adhesion molecules : proceedings of a conference held on April 15-16, 1996, in New Orleans, USA, supported by an educational grant from Boehringer Ingelheim |
|
| Nihon Enshō Gakkai. Winter Seminar (1983 : Tokyo, Japan). Pers. in prostaglandin res., 1983: |
|
| A patient's guide to coronary bypass surgery and its aftermath : advice from a survivor |
|
| Pharmacologic properties of the new nitric oxide donor ITF 296 |
|
| Prostacyclin |
|
| Prostaglandin synthetase inhibitors : their effects on physiological functions and pathological states ; sponsored jointly by the Royal Society of Medicine Foundation, inc. of New York and the Royal Society of Medicine of London, held November 28-30, 1973 at the Rockefeller University, New York City |
|
| The pulmonary circulation and acute lung injury |
|
| The refractory period of atria isolated from mammalian hearts |
|
| Regional vascular resistance and haemodynamics in the spontaneously hypertensive rat: the effects of bradykinin |
|
| The relation between the motor and inhibitor actions of acetylcholine |
|
| The relationship between the penetration of tryptamine and 5-hydroxytryptamine into smooth muscle and the associated contractions |
|
| The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation |
|
| The release of catecholamines by shocks and stimuli paired with shocks |
|
| The release of catecholamines from the adrenal medulla by peptides |
|
| Release of prostaglandin E-1 from the rat stomach. |
|
| The release of rabbit aorta contracting substance (RCS) from chopped lung and its antagonism by anti-inflammatory drugs |
|
| Release of renal prostaglandins during endotoxin-induced hypotension |
|
| Release of vaso-active substances from lungs by injection of particles |
|
| The renin--angiotensin system: inhibition of converting enzyme in isolated tissues |
|
| The research heritage of Henry Wellcome. |
|
| Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock |
|
| The role of chemical mediators released by the endothelium in the control of the cardiovascular system |
|
| The role of circulating catecholamines in arterial baroceptor reflexes in the dog and in man |
|
| The role of prostaglandins in the local control of circulation |
|
| Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists |
|
| Selective COX-2 inhibitors : pharmacology, clinical effects, and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France |
|
| Selective proteolitic activation and degradation of ETs and big ETs in parenchymal strips of the guinea-pig lung |
|
| A sensitive method for the assay of 5-hydroxytryptamine. 1957 |
|
| Simultaneous measurement of endothelium-derived relaxing factor by bioassay and guanylate cyclase stimulation |
|
| Sir John Robert Vane (1927-2004) |
|
| Sites of uptake of 3H-5-hydroxytryptamine in rat isolated lung |
|
| Sodium nitroprusside modulates the fibrinolytic system in the rabbit |
|
| Some characteristics of the prostaglandin synthesizing system in rabbit kidney microsomes |
|
| Some pharmacological actions of paludrine |
|
| Structural requirements for opioid activity of analogues of the enkephalins |
|
| Studies on the importance of the proposed release of nitric oxide from platelets |
|
| Study of the mechanisms of the modifying actions of hexamethonium on the cardiovascular response to norepinephrine |
|
| Support of renal blood flow after ischaemic‐reperfusion injury by endogenous formation of nitric oxide and of cyclo‐oxygenase vasodilator metabolites |
|
| Suppression of intestinal polyposis by inhibition of COX-2 in Apc knockout mice |
|
| Synthesis of 6-keto-PGF1alpha by ram seminal vesicle microsomes |
|
| Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition of platelet aggregation |
|
| The technique of superfusion |
|
| Tetrahydrobiopterin synthesis is induced by LPS in vascular smooth muscle and is rate-limiting for nitric oxide production. |
|
| Therapeutic applications of prostaglandins |
|
| Tryptamine Receptors in the Central Nervous System: Effects of Anæsthetics |
|
| The use of isolated organs for detecting active substances in the circulating blood. 1964 |
|
| The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors |
|
| Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. |
|
| Vascular actinos of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog |
|
| Vasoconstriction in the rat kidney induced by endothelin-1 is blocked by PD 145065. |
|
